MRIシステム市場 – 2030年までの世界予測

本調査レポートは、MRIシステム市場を製品、サンプル調製技術、用途、エンドユーザー、地域別に分析しています。市場拡大の要因を網羅し、現在各業界が直面している見通しとパラメータを分析し、市場リーダー企業と中小企業を考慮した競争環境の詳細を提供します。また、5つの地域とミクロ市場分析に基づき、各市場セグメントの収益を推定しています。

The global MRI systems market is projected to reach USD 9.0 billion by 2030 from USD 6.5 billion in 2025, at a CAGR of 6.5% from 2025 to 2030.

世界の MRIシステム市場は、2025 年の 65 億米ドルから 2030 年には 90 億米ドルに達し、2025 年から 2030 年にかけて 6.5% の CAGR で成長すると予測されています。

The market’s growth can be attributed to an increase in disease burden, specifically for neurological and musculoskeletal conditions, which is projected to increase in the coming years. An increase in the aging population, with the rising prevalence of chronic diseases such as cancer, is anticipated to increase the need for MRI systems across the globe. All these factors, on a broader level, will help to grow the market for MRI systems.

市場の成長は、特に神経系および筋骨格系疾患における疾病負担の増加に起因しており、今後数年間で増加すると予測されています。高齢化の進展と、がんなどの慢性疾患の罹患率の上昇により、世界中でMRIシステムのニーズが増加すると予想されています。これらの要因すべてが、より広範なレベルでMRIシステム市場の成長を促進するでしょう。

By field strength, the high & very high field segment dominated the MRI systems market in 2024.

The MRI systems market is categorized by field strength, encompassing low-to-mid-field MRI systems, high and very high field MRI systems, and ultra-high-field MRI systems. High and very high field MRI systems are notable for their superior signal-to-noise ratio (SNR), which enhances clinical utility significantly. These systems are not only instrumental in imaging the brain, musculoskeletal structures, and vascular systems but also excel in specialized applications within psychiatry, neurology, biomedical research, and the early identification of conditions such as multiple sclerosis. The integration of MRI with complementary modalities such as PET and ultrasound further optimizes operational throughput and decreases helium usage while also delivering faster scan times and enhanced image resolution. High-field MRI systems, specifically those operating at 1.5T and 3T, are favored over low-field systems (below 1T) due to their markedly superior image quality, reduced acquisition times, and extensive range of clinical applications. The elevated SNR in high-field systems translates to clearer, more detailed imaging essential for diagnosing complex conditions such as neurological disorders, musculoskeletal injuries, and cardiovascular abnormalities. The rapid scan capabilities not only improve patient throughput but also enhance operational efficiency within healthcare facilities. Collectively, these factors have driven the growing adoption of high-field MRI systems within the market.

By architecture, the closed MRI systems segment accounted for the largest share of the market in 2024.

A closed MRI scanner utilizes a small cylindrical chamber to produce highly detailed images of the body’s structure. Most high-field superconducting magnetic resonance imaging scanners are designed in a closed format. Due to their higher efficiency, superior image quality, and increased throughput—all resulting from greater magnetic field strengths—closed MRI systems are considered the industry standard. In contrast to open MRI systems, which may require up to four or five scans for a comparable evaluation, closed MRI systems typically complete the scanning process in just one or two scans. This efficiency not only shortens examination times but also enhances the clinical utility of procedures and therapies. Closed MRI offers faster scan times, which helps reduce motion artifacts and improves patient throughput, making it particularly suitable for high-volume hospitals and diagnostic centers. Additionally, it supports advanced imaging techniques such as functional MRI (fMRI), diffusion-weighted imaging (DWI), and cardiac MRI, all of which rely on high-field strength for precision.

By design, the fixed/stationary MRI systems segment accounted for the largest share of the market in 2024.

The market for MRI systems is divided into two main categories: fixed (or stationary) MRI systems and portable MRI systems. Fixed MRI systems are generally preferred over portable ones for several reasons. They offer superior image quality, the ability to conduct full-body scans, improved workflow efficiency, and better long-term cost-effectiveness. Typically, fixed MRI units operate at a magnetic field. Another significant advantage of fixed MRI systems is their capability for full-body imaging, which further fuels market growth.

By application, the brain & neurological MRI segment has registered the highest growth rate during the forecast period.

Based on applications, the MRI systems market is segmented into brain & neurological MRI, spine & musculoskeletal MRI, pelvic & abdominal MRI, vascular MRI, breast MRI, cardiac MRI, pediatric MRI, and other applications. The brain & neurological MRI segment of the MRI systems market by application is expected to register the highest growth rate during the forecast period. Key drivers contributing to the rapid growth of this segment include the integration of sophisticated AI technologies as well as the increasing adoption of innovative devices that enable accurate targeting of internal organs, thereby facilitating real-time imaging capabilities.

By end user, the hospitals segment accounted for the largest share of the market in 2024.

The global MRI systems market is classified by end users into hospitals, diagnostic imaging centers, and other categories. In 2024, the hospital segment held the largest market share. This dominance is primarily due to the increased use of advanced MRI systems in hospitals, which enhance accurate diagnosis and raise awareness of the importance of early detection. Contributing factors include recent product launches, the growing adoption of advanced systems with improved features that support patient care, and a rising number of imaging procedures conducted in hospitals. As the demand for rapid and precise diagnoses of various medical conditions grows, many hospitals are prioritizing the installation of advanced MRI systems. Large government hospitals with dedicated imaging units have been early adopters of these technologies, while private hospitals are increasingly embracing advanced imaging solutions over time. The trend towards modernizing imaging workflows has further driven the adoption of MRI systems in hospitals.

“The Asia Pacific market is projected to show the highest growth rate in the MRI systems market.”

The MRI systems market spans five primary regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Notably, the Asia Pacific region houses a significant number of MRI systems manufacturers that deliver a comprehensive range of MRI modalities equipped with advanced technological features, all while maintaining competitive pricing. End users, particularly in healthcare institutions, are increasingly facing budget constraints exacerbated by recent tariff sanctions; this has prompted a shift towards more cost-effective MRI solutions offered by Chinese manufacturers. The region’s manufacturing landscape benefits from low labor costs and abundant resources, facilitating efficient production processes for MRI systems. These dynamics position the Asia Pacific market to experience the highest growth rate within the global landscape, driven by both increased local demand and the strategic pricing of offerings.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1—20%, Tier 2—45%, and Tier 3—35%
• By Designation: C-level—30%, Directors—20%, and Others—50%
• By Region: North America—36%, Europe—25%, Asia Pacific—27%, Latin America—9%, and the Middle East & Africa—3%

The key players profiled in the MRI systems market are Siemens Healthineers (Germany),  GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Canon Inc. (Japan), Fonar Corporation (US),  Esaote S.p.A (Italy), Shanghai United Imaging Healthcare Co., Ltd (China), Aspect Imaging Ltd. (US), and Time Medical Holding (Hong Kong).

Research Coverage

The research report examines the MRI systems market by product, sample preparation technique, application, end-users, and geography. This research covers factors that are driving market expansion, analyzes prospects and parameters faced by industries in the present time, and provides specifics on the competitive landscape considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions and micro-market analysis.

Rationale to Buy the Report

The report will provide market leaders and new entrants with valuable information regarding the revenue estimates for the overall MRI systems market and its subsegments. It will help stakeholders understand the competitive landscape, allowing them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into the market dynamics, including key drivers, restraints, challenges, and opportunities.

This report provides insightful data on the following points:

• Market Penetration: In-depth coverage of product portfolios offered by the top players in the MRI systems market
• Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the MRI systems market
• Market Development: Insightful data on profitable developing areas
• Market Diversification: Details about recent developments and advancements in the MRI systems market
• Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors

Table of Contents

1               INTRODUCTION              24

1.1           STUDY OBJECTIVES       24

1.2           MARKET DEFINITION   24

1.3           STUDY SCOPE   25

1.3.1        MARKET SEGMENTATION AND REGIONAL SCOPE                 25

1.3.2        INCLUSIONS & EXCLUSIONS       26

1.4           YEARS CONSIDERED      26

1.5           CURRENCY CONSIDERED            26

1.6           RESEARCH LIMITATIONS             27

1.7           KEY STAKEHOLDERS     27

1.8           SUMMARY OF CHANGES               28

2               RESEARCH METHODOLOGY       29

2.1           RESEARCH DATA              29

2.1.1        SECONDARY DATA          30

2.1.2        PRIMARY DATA 31

2.1.2.1    Key primary sources             31

2.1.2.2    Key industry insights           32

2.1.2.3    Breakdown of primaries      32

2.2           MARKET SIZE ESTIMATION         33

2.2.1        APPROACH 1: COMPANY REVENUE ESTIMATION                 35

2.2.2        APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION     36

2.2.3        GROWTH FORECAST      37

2.2.4        CAGR PROJECTIONS      38

2.3           DATA TRIANGULATION                39

2.4           MARKET SHARE ESTIMATION    40

2.5           RESEARCH ASSUMPTIONS           40

2.6           RISK ASSESSMENT           41

2.7           GROWTH RATE ASSUMPTIONS 41

3               EXECUTIVE SUMMARY  42

4               PREMIUM INSIGHTS       47

4.1           OPPORTUNITIES FOR PLAYERS IN MRI SYSTEMS MARKET               47

4.2           EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2025 VS. 2030 (USD MILLION)      48

4.3           NORTH AMERICA: MRI SYSTEMS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)       49

4.4           ASIA PACIFIC: MRI SYSTEMS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      50

4.5           MRI SYSTEMS MARKET: GEOGRAPHICAL SNAPSHOT                 51

5               MARKET OVERVIEW       52

5.1           INTRODUCTION              52

5.2           MARKET DYNAMICS       52

5.2.1        DRIVERS               53

5.2.1.1    Public-private partnerships to scale diagnostic imaging landscape                 53

5.2.1.2    Growing prevalence of MSDs and increasing geriatric population to boost demand   54

5.2.1.3    Integration of iMRI into surgery to catalyze growth of MRI systems market     54

5.2.2        RESTRAINTS      55

5.2.2.1    Complex operations and maintenance of MRI systems 55

5.2.2.2    Premium pricing of MRI systems      55

5.2.2.3    Global helium shortage        56

5.2.3        OPPORTUNITIES              56

5.2.3.1    Emergence of helium-free MRI systems           56

5.2.3.2    AI integration with MRI technology for process optimization                 57

5.2.4        CHALLENGES    57

5.2.4.1    Limited capital budgets       57

5.2.4.2    Dearth of trained and skilled professionals      57

5.3           PORTER’S FIVE FORCES ANALYSIS           58

5.4           REGULATORY LANDSCAPE         60

5.4.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             60

5.4.2        REGULATIONS, BY REGION         62

5.4.2.1    North America      62

5.4.2.1.1 US           62

5.4.2.1.2 Canada   63

5.4.2.2    Europe   64

5.4.2.3    Asia Pacific            64

5.4.2.3.1 Japan      64

5.4.2.3.2 China      65

5.4.2.3.3 India       67

5.5           REIMBURSEMENT SCENARIO ANALYSIS                 67

5.5.1        RELEVANT REIMBURSEMENT CODE, BY COUNTRY                 67

5.5.2        REIMBURSEMENT TRENDS, BY REGION, 2022–2024                 69

5.5.2.1    North America      69

5.5.2.2    Europe   70

5.5.2.3    Asia Pacific            71

5.5.2.4    Latin America       72

5.5.2.5    Middle East & Africa            72

5.6           ECOSYSTEM ANALYSIS  73

5.7           VALUE CHAIN ANALYSIS               74

5.7.1        R&D       75

5.7.2        RAW MATERIAL PROCUREMENT AND PRODUCT DEVELOPMENT                75

5.7.3        MARKETING, SALES, AND DISTRIBUTION            76

5.7.4        AFTERMARKET SERVICES             76

5.8           SUPPLY CHAIN ANALYSIS             76

5.8.1        PROMINENT COMPANIES            77

5.8.2        SMALL AND MEDIUM-SIZED ENTERPRISES          77

5.8.3        END USERS         77

5.8.4        SALES AND DISTRIBUTION         77

5.9           PRICING ANALYSIS          77

5.9.1        AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2022–2024        77

5.9.2        AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024                 80

5.10         PATENT ANALYSIS          83

5.11         TRADE ANALYSIS             85

5.11.1      IMPORT SCENARIO         85

5.11.2      EXPORT SCENARIO         86

5.12         TECHNOLOGY ANALYSIS             87

5.12.1      KEY TECHNOLOGIES     87

5.12.1.1  Ultrafast imaging technologies           87

5.12.1.2  Ultra-high-field MRI            87

5.12.2      COMPLEMENTARY TECHNOLOGIES       88

5.12.2.1  Advanced coil technology    88

5.12.2.2  Weight-bearing MRI imaging             88

5.12.3      ADJACENT TECHNOLOGIES       88

5.12.3.1  AI and machine learning in MRI imaging         88

5.13         TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            89

5.14         INVESTMENT & FUNDING SCENARIO     90

5.15         KEY CONFERENCES AND EVENTS, 2025–2026        92

5.16         KEY STAKEHOLDERS AND BUYING CRITERIA     93

5.16.1      KEY STAKEHOLDERS IN BUYING PROCESS           93

5.16.2      KEY BUYING CRITERIA  94

5.17         CASE STUDY ANALYSIS 95

5.17.1      EXPANDING ACCESS TO MRI SYSTEMS  95

5.18         MRI SCAN APPLICATIONS, 2022–2024       95

5.19         IMPACT OF AI ON MRI SYSTEMS MARKET             97

5.19.1      INTRODUCTION              97

5.19.2      MARKET POTENTIAL OF MRI SYSTEMS 97

5.19.3      KEY COMPANIES IMPLEMENTING AI      98

5.19.4      FUTURE OF AI IN MRI SYSTEMS MARKET ECOSYSTEM                 98

5.20         US TARIFF 2025 98

5.20.1      INTRODUCTION              98

5.20.2      KEY TARIFF RATES          99

5.20.3      PRICE IMPACT ANALYSIS             100

5.20.4      IMPACT ON COUNTRY/REGION                101

5.20.4.1  US           101

5.20.4.2  Europe   101

5.20.4.3  Asia Pacific            101

5.20.5      IMPACT ON END USE INDUSTRIES          101

6               MRI SYSTEMS MARKET, BY APPLICATION             102

6.1           INTRODUCTION              103

6.2           BRAIN & NEUROLOGICAL MRI   103

6.2.1        RISE IN NEURODEGENERATIVE DISEASES TO DRIVE MARKET               103

6.3           SPINE & MUSCULOSKELETAL MRI            105

6.3.1        GROWING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET                 105

6.4           VASCULAR MRI 106

6.4.1        USE OF VASCULAR MRI AS ALTERNATIVE TO CT TO SUPPORT MARKET GROWTH     106

6.5           PELVIC & ABDOMINAL MRI         107

6.5.1        NEED FOR DETECTING PROSTATE AND CERVICAL CANCERS TO PROPEL MARKET 107

6.6           BREAST MRI       108

6.6.1        GROWING AWARENESS REGARDING EARLY BREAST CANCER SCREENING TO DRIVE MARKET              108

6.7           CARDIAC MRI    108

6.7.1        RISING INCIDENCE OF CVD TO SUPPORT MARKET GROWTH             108

6.8           PEDIATRIC MRI 109

6.8.1        NEED FOR EFFICIENT DIAGNOSTIC ACCURACY AND EARLY DETECTION TO PROMOTE USE OF PEDIATRIC MRI                 109

6.9           OTHER APPLICATIONS 110

7               MRI SYSTEMS MARKET, BY ARCHITECTURE        111

7.1           INTRODUCTION              112

7.2           CLOSED MRI SYSTEMS  113

7.2.1        STANDARD BORE MRI SYSTEMS                114

7.2.1.1    High accuracy and improved sensitivity of systems to propel market    114

7.2.2        WIDE-BORE MRI SYSTEMS           115

7.2.2.1    High-quality MRI images and improved patient comfort to drive market    115

7.3           OPEN MRI SYSTEMS        115

7.3.1        USE OF OPEN MRI SYSTEMS FOR CHILDREN AND OBESE PATIENTS TO DRIVE MARKET   115

8               MRI SYSTEMS MARKET, BY DESIGN         117

8.1           INTRODUCTION              118

8.2           FIXED/STATIONARY MRI SYSTEMS          119

8.2.1        FLOOR-FIXED MRI SYSTEMS       120

8.2.1.1    High flexibility and low initial installation costs to drive demand                 120

8.2.2        CEILING-FIXED MRI SYSTEMS    121

8.2.2.1    Need for MRI systems with high stability and more space to drive market    121

8.3           PORTABLE MRI SYSTEMS             122

8.3.1        ADOPTION OF PORTABLE/MOBILE MRI SYSTEMS DUE TO THEIR COST-EFFECTIVENESS AND FLEXIBILITY TO BOOST GROWTH             122

9               MRI SYSTEMS MARKET, BY FIELD STRENGTH     123

9.1           INTRODUCTION              124

9.2           HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS         124

9.2.1        1.5T        126

9.2.1.1    Rising use of 1.5T MRI systems for routine examinations to propel market        126

9.2.2        3T            127

9.2.2.1    Increasing use of 3T MRI systems to obtain high-quality images to drive market      127

9.3           LOW-TO-MID-FIELD MRI SYSTEMS          128

9.3.1        RISING ADOPTION OF OXYGEN-ENHANCED MRI SYSTEMS TO DRIVE MARKET      128

9.4           ULTRA-HIGH-FIELD MRI SYSTEMS           129

9.4.1        RISING INNOVATION AND ADVANCEMENTS TO SUPPORT DEMAND FOR ULTRA-HIGH-FIELD SYSTEMS 129

10            MRI SYSTEMS MARKET, BY END USER    131

10.1         INTRODUCTION              132

10.2         HOSPITALS         132

10.2.1      INCREASING ADOPTION OF ADVANCED MRI SYSTEMS TO PROPEL MARKET      132

10.3         DIAGNOSTIC IMAGING CENTERS             134

10.3.1      RISING DEVELOPMENT OF PRIVATE IMAGING CENTERS TO FUEL MARKET            134

10.4         OTHER END USERS         135

11            MRI SYSTEMS MARKET, BY REGION         136

11.1         INTRODUCTION              137

11.2         NORTH AMERICA             138

11.2.1      NORTH AMERICA: MACROECONOMIC OUTLOOK                 138

11.2.2      US           142

11.2.2.1  Strategic reforms in reimbursements and partnerships to drive market    142

11.2.3      CANADA               144

11.2.3.1  Progressive government policies and growing pulse of diagnostic imaging to spur market        144

11.3         EUROPE               145

11.3.1      EUROPE: MACROECONOMIC OUTLOOK               145

11.3.2      GERMANY           149

11.3.2.1  Digital push in healthcare access and supportive government policies to drive market       149

11.3.3      UK          150

11.3.3.1  Strategic developments in diagnostic imaging niche to propel market    150

11.3.4      FRANCE                151

11.3.4.1  Increasing patient population and reforms in MRI coverage policies to boost growth       151

11.3.5      ITALY    152

11.3.5.1  Progressive government initiatives and strong corporate collaborations to propel       152

11.3.6      SPAIN    153

11.3.6.1  Strategic policy reforms and technological advancements in preclinical MRI to drive market          153

11.3.7      REST OF EUROPE             154

11.4         ASIA PACIFIC     155

11.4.1      ASIA PACIFIC: MACROECONOMIC OUTLOOK     156

11.4.2      JAPAN   161

11.4.2.1  Strong healthcare infrastructure and supportive government reimbursement policies to boost growth           161

11.4.3      CHINA  162

11.4.3.1  Policy reforms, progressive infrastructure plans, and foreign collaborations to boost market            162

11.4.4      INDIA    163

11.4.4.1  Industry collaboration and public-private synergy to expand diagnostic imaging landscape             163

11.4.5      AUSTRALIA         164

11.4.5.1  New research initiatives and policy enhancements to promote growth    164

11.4.6      SOUTH KOREA  165

11.4.6.1  Supportive government policies to promote growth       165

11.4.7      REST OF ASIA PACIFIC   166

11.5         LATIN AMERICA                167

11.5.1      LATIN AMERICA: MACROECONOMIC OUTLOOK                 168

11.5.2      BRAZIL 172

11.5.2.1  Increased burden of diseases and growing adoption of healthcare insurance to drive market   172

11.5.3      MEXICO                173

11.5.3.1  Industry partnerships to drive market growth 173

11.5.4      REST OF LATIN AMERICA             174

11.6         MIDDLE EAST & AFRICA                175

11.6.1      MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK                 175

11.6.2      GCC COUNTRIES              179

11.6.2.1  Favorable government initiatives to contribute to market growth                 179

11.6.3      REST OF MIDDLE EAST & AFRICA             180

11.6.3.1  Increased adoption of mass spectrometers to contribute to growth                 180

12            COMPETITIVE LANDSCAPE         182

12.1         INTRODUCTION              182

12.2         KEY PLAYERS’ STRATEGIES/RIGHT TO WIN         182

12.3         REVENUE SHARE ANALYSIS, 2020–2024    184

12.4         MARKET SHARE ANALYSIS           185

12.5         RANKING OF KEY PLAYERS, 2024               187

12.6         COMPANY VALUATION AND FINANCIAL METRICS                 187

12.7         BRAND/PRODUCT COMPARISON             189

12.8         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 190

12.8.1      STARS   190

12.8.2      PERVASIVE PLAYERS      190

12.8.3      EMERGING LEADERS     190

12.8.4      PARTICIPANTS 190

12.8.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         192

12.8.5.1  Company footprint               192

12.8.5.2  Field strength footprint       193

12.8.5.3  Application footprint            194

12.8.5.4  End user footprint                 195

12.8.5.5  Region footprint   196

12.9         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        197

12.9.1      PROGRESSIVE COMPANIES         197

12.9.2      RESPONSIVE COMPANIES            197

12.9.3      DYNAMIC COMPANIES  197

12.9.4      STARTING BLOCKS         197

12.9.5      COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024        199

12.9.5.1  Detailed list of key startups/SMEs    199

12.9.5.2  Competitive benchmarking of key startups/SMEs          200

12.10       COMPETITIVE SCENARIO             201

12.10.1   PRODUCT LAUNCHES AND APPROVALS               201

12.10.2   DEALS  202

12.10.3   EXPANSIONS     203

13            COMPANY PROFILES      204

13.1         KEY PLAYERS     204

13.1.1      SIEMENS HEALTHINEERS             204

13.1.1.1  Business overview 204

13.1.1.2  Products offered   205

13.1.1.3  Recent developments           206

13.1.1.3.1                Product launches and approvals         206

13.1.1.3.2                Deals      207

13.1.1.3.3                Expansions             208

13.1.1.4  MnM view              208

13.1.1.4.1                Key strengths/Right to win 208

13.1.1.4.2                Strategic choices   208

13.1.1.4.3                Weaknesses and competitive threats 208

13.1.2      KONINKLIJKE PHILIPS N.V.          209

13.1.2.1  Business overview 209

13.1.2.2  Products offered   210

13.1.2.3  Recent developments           211

13.1.2.3.1                Product launches and approvals         211

13.1.2.3.2                Deals      211

13.1.2.3.3                Expansions             211

13.1.2.4  MnM view              212

13.1.2.4.1                Key strengths/Right to win 212

13.1.2.4.2                Strategic choices   212

13.1.2.4.3                Weaknesses and competitive threats 212

13.1.3      GE HEALTHCARE             213

13.1.3.1  Business overview 213

13.1.3.2  Products offered   214

13.1.3.3  Recent developments           215

13.1.3.3.1                Product launches and approvals         215

13.1.3.3.2                Deals      215

13.1.3.3.3                Expansions             216

13.1.3.4  MnM view              216

13.1.3.4.1                Key strengths/Right to win 216

13.1.3.4.2                Strategic choices   216

13.1.3.4.3                Weaknesses and competitive threats 217

13.1.4      CANON MEDICAL SYSTEMS        218

13.1.4.1  Business overview 218

13.1.4.2  Products offered   219

13.1.4.3  Recent developments           220

13.1.4.3.1                Product launches and approvals         220

13.1.4.3.2                Deals      220

13.1.4.4  MnM view              221

13.1.4.4.1                Key strengths/Right to win 221

13.1.4.4.2                Strategic choices   221

13.1.4.4.3                Weaknesses and competitive threats 221

13.1.5      FUJIFILM CORPORATION             222

13.1.5.1  Business overview 222

13.1.5.2  Products offered   223

13.1.5.3  Recent developments           224

13.1.5.3.1                Product launches and approvals         224

13.1.5.3.2                Deals      224

13.1.5.4  MnM view              225

13.1.5.4.1                Key strengths/Right to win 225

13.1.5.4.2                Strategic choices   225

13.1.5.4.3                Weaknesses and competitive threats 225

13.1.6      FONAR CORPORATION 226

13.1.6.1  Business overview 226

13.1.6.2  Products offered   227

13.1.6.3  Recent developments           227

13.1.6.3.1                Deals      227

13.1.7      ESAOTE S.P.A     228

13.1.7.1  Business overview 228

13.1.7.2  Products offered   228

13.1.7.3  Recent developments           229

13.1.7.3.1                Product launches and approvals         229

13.1.7.3.2                Deals      229

13.1.8      SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.                 230

13.1.8.1  Business overview 230

13.1.8.2  Products offered   231

13.1.8.3  Recent developments           231

13.1.8.3.1                Product launches and approvals         231

13.1.8.3.2                Deals      232

13.1.8.3.3                Expansions             232

13.1.9      ASPECT IMAGING LTD. 233

13.1.9.1  Business overview 233

13.1.9.2  Products offered   233

13.1.10   TIME MEDICAL HOLDING            234

13.1.10.1                 Business overview 234

13.1.10.2                 Products offered   234

13.1.10.3                 Recent developments           235

13.1.10.3.1             Product launches and approvals         235

13.1.10.3.2             Deals      235

13.1.10.3.3             Expansions             235

13.1.11   NEUSOFT MEDICAL SYSTEMS CO., LTD.                236

13.1.11.1                 Business overview 236

13.1.11.2                 Products offered   236

13.1.11.3                 Recent developments           237

13.1.11.3.1             Deals      237

13.1.12   STERNMED GMBH           238

13.1.12.1                 Business overview 238

13.1.12.2                 Products offered   238

13.1.12.3                 Recent developments           238

13.1.12.3.1             Deals      238

13.1.13   HYPERFINE, INC.              239

13.1.13.1                 Business overview 239

13.1.13.2                 Products offered   240

13.1.13.3                 Recent developments           240

13.1.13.3.1             Deals      240

13.1.14   SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.                 241

13.1.14.1                 Business overview 241

13.1.14.2                 Products offered   241

13.1.15   SHENZHEN ANKE HIGH-TECH., LTD.      242

13.1.15.1                 Business overview 242

13.1.15.2                 Products offered   242

13.2         OTHER PLAYERS              243

13.2.1      MAGNETICA LTD             243

13.2.2      AURORA HEALTHCARE US CORP              244

13.2.3      INNERVISION MRI LTD. 245

13.2.4      BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.                 246

13.2.5      MEDONICA CO., LTD     247

13.2.6      NEOSCAN SOLUTIONS GMBH    247

13.2.7      KANGDA INTERCONTINENTAL MEDICAL EQUIPMENT CO., LTD.             248

13.2.8      MINFOUND MEDICAL SYSTEMS CO., LTD.            249

13.2.9      SYNAPTIVE MEDICAL    250

13.2.10   XINGAOYI MEDICAL EQUIPMENT CO., LTD         250

14            APPENDIX           251

14.1         DISCUSSION GUIDE        251

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                256

14.3         CUSTOMIZATION OPTIONS        258

14.4         RELATED REPORTS         258

14.5         AUTHOR DETAILS           259

LIST OF TABLES

TABLE 1                MARKET DYNAMICS: IMPACT ANALYSIS                 53

TABLE 2                IMPACT OF PORTER’S FORCES ON MRI SYSTEMS MARKET               58

TABLE 3                REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           61

TABLE 4                US FDA: MEDICAL DEVICE CLASSIFICATION                 62

TABLE 5                US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              63

TABLE 6                CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS      63

TABLE 7                JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA   65

TABLE 8                CHINA: CLASSIFICATION OF MEDICAL DEVICES                 65

TABLE 9                NORTH AMERICA: RELEVANT MRI REIMBURSEMENT CODE               68

TABLE 10              EUROPE: RELEVANT MRI REIMBURSEMENT CODE    68

TABLE 11              ASIA PACIFIC: RELEVANT MRI REIMBURSEMENT CODE    69

TABLE 12              ROLE OF COMPANIES/ORGANIZATIONS IN MARKET ECOSYSTEM    74

TABLE 13              AVERAGE SELLING PRICING TREND OF MRI SYSTEMS, BY KEY PLAYER,

2022–2024              80

TABLE 14              AVERAGE SELLING PRICING TREND OF MRI SYSTEMS, BY REGION,

2022–2024              82

TABLE 15              INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024              84

TABLE 16              IMPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY,

2020–2024 (USD THOUSAND)      85

TABLE 17              EXPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY,

2020–2024 (USD THOUSAND)      86

TABLE 18              KEY CONFERENCES AND EVENTS, 2025–2026                 92

TABLE 19              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY FIELD STRENGTH 93

TABLE 20              KEY BUYING CRITERIA, BY END USER    94

TABLE 21              EXPANDING ACCESS TO MRI SYSTEMS  95

TABLE 22              MRI SCAN APPLICATIONS, BY REGION, 2022 (‘000 UNITS) 95

TABLE 23              MRI SCAN APPLICATIONS, BY REGION, 2023 (‘000 UNITS) 96

TABLE 24              MRI SCAN APPLICATIONS, BY REGION, 2024 (‘000 UNITS) 96

TABLE 25              RECIPROCAL TARIFF RATES ADJUSTED BY US                 99

TABLE 26              MRI SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)       103

TABLE 27              MRI SYSTEMS MARKET FOR BRAIN & NEUROLOGICAL MRI, BY REGION,

2023–2030 (USD MILLION)            104

TABLE 28              MRI SYSTEMS MARKET FOR SPINE & MUSCULOSKELETAL MRI, BY REGION,

2023–2030 (USD MILLION)            105

TABLE 29              MRI SYSTEMS MARKET FOR VASCULAR MRI, BY REGION,

2023–2030 (USD MILLION)            106

TABLE 30              MRI SYSTEMS MARKET FOR PELVIC & ABDOMINAL MRI, BY REGION,

2023–2030 (USD MILLION)            107

TABLE 31              MRI SYSTEMS MARKET FOR BREAST MRI, BY REGION, 2023–2030 (USD MILLION)          108

TABLE 32              MRI SYSTEMS MARKET FOR CARDIAC MRI, BY REGION,

2023–2030 (USD MILLION)            109

TABLE 33              MRI SYSTEMS MARKET FOR PEDIATRIC MRI, BY REGION,

2023–2030 (USD MILLION)            110

TABLE 34              MRI SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            110

TABLE 35              MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION)            112

TABLE 36              CLOSED MRI SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)       113

TABLE 37              CLOSED MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)            114

TABLE 38              STANDARD BORE MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)          114

TABLE 39              WIDE-BORE MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)            115

TABLE 40              OPEN MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)       116

TABLE 41              MRI SYSTEMS MARKET, BY DESIGN, 2023–2030 (USD MILLION) 118

TABLE 42              FIXED/STATIONARY MRI SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)                119

TABLE 43              FIXED/STATIONARY MRI SYSTEMS MARKET, BY REGION,

2023–2030 (USD MILLION)            119

TABLE 44              FLOOR-FIXED MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)          120

TABLE 45              CEILING-FIXED MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)          121

TABLE 46              PORTABLE MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)            122

TABLE 47              MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)            124

TABLE 48              HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION,

2023–2030 (USD MILLION)            125

TABLE 49              HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION,

2022–2024 (UNITS)            125

TABLE 50              1.5T MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)       126

TABLE 51              1.5T MRI SYSTEMS MARKET, BY REGION, 2022–2024 (UNITS)      126

TABLE 52              3T MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)       127

TABLE 53              3T MRI SYSTEMS MARKET, BY REGION, 2022–2024 (UNITS)      127

TABLE 54              LOW-TO-MID-FIELD MRI SYSTEMS MARKET, BY REGION,

2023–2030 (USD MILLION)            128

TABLE 55              LOW-TO-MID-FIELD MRI SYSTEMS MARKET, BY REGION, 2022–2024 (UNITS)         129

TABLE 56              ULTRA-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION,

2023–2030 (USD MILLION)            130

TABLE 57              ULTRA-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION, 2022–2024 (UNITS)         130

TABLE 58              MRI SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 132

TABLE 59              MRI SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)          133

TABLE 60              MRI SYSTEMS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION,

2023–2030 (USD MILLION)            134

TABLE 61              MRI SYSTEMS MARKET FOR OTHER END USERS, BY REGION,

2023–2030 (USD MILLION)            135

TABLE 62              MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 137

TABLE 63              NORTH AMERICA: MACROECONOMIC OUTLOOK           138

TABLE 64              NORTH AMERICA: MRI SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            139

TABLE 65              NORTH AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            140

TABLE 66              NORTH AMERICA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         140

TABLE 67              NORTH AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,

2023–2030 (USD MILLION)            140

TABLE 68              NORTH AMERICA: CLOSED MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            141

TABLE 69              NORTH AMERICA: MRI SYSTEMS MARKET, BY DESIGN, 2023–2030 (USD MILLION)          141

TABLE 70              NORTH AMERICA: FIXED/STATIONARY MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         141

TABLE 71              NORTH AMERICA: MRI SYSTEMS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            142

TABLE 72              NORTH AMERICA: MRI SYSTEMS MARKET, BY END USER,

2023–2030 (USD MILLION)            142

TABLE 73              US: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)   143

TABLE 74              US: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            143

TABLE 75              CANADA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            144

TABLE 76              CANADA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         145

TABLE 77              EUROPE: MACROECONOMIC OUTLOOK                 146

TABLE 78              EUROPE: MRI SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            146

TABLE 79              EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            146

TABLE 80              EUROPE: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            147

TABLE 81              EUROPE: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION)         147

TABLE 82              EUROPE: CLOSED MRI SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)                147

TABLE 83              EUROPE: MRI SYSTEMS MARKET, BY DESIGN, 2023–2030 (USD MILLION)            148

TABLE 84              EUROPE: FIXED/STATIONARY MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            148

TABLE 85              EUROPE: MRI SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              148

TABLE 86              EUROPE: MRI SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION)            149

TABLE 87              GERMANY: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            150

TABLE 88              GERMANY: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         150

TABLE 89              UK: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)   151

TABLE 90              UK: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            151

TABLE 91              FRANCE: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            152

TABLE 92              FRANCE: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS, BY TYPE,

2023–2030 (USD MILLION)            152

TABLE 93              ITALY: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)   153

TABLE 94              ITALY: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         153

TABLE 95              SPAIN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)   154

TABLE 96              SPAIN: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         154

TABLE 97              REST OF EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            155

TABLE 98              REST OF EUROPE: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         155

TABLE 99              ASIA PACIFIC: MACROECONOMIC OUTLOOK                 156

TABLE 100            ASIA PACIFIC: MRI SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     158

TABLE 101            ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            158

TABLE 102            ASIA PACIFIC: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         158

TABLE 103            ASIA PACIFIC: MRI SYSTEMS MARKET, BY ARCHITECTURE,

2023–2030 (USD MILLION)            159

TABLE 104            ASIA PACIFIC: CLOSED MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            159

TABLE 105            ASIA PACIFIC: MRI SYSTEMS MARKET, BY DESIGN, 2023–2030 (USD MILLION)          159

TABLE 106            ASIA PACIFIC: FIXED/STATIONARY MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         160

TABLE 107            ASIA PACIFIC: MRI SYSTEMS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            160

TABLE 108            ASIA PACIFIC: MRI SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION)                160

TABLE 109            JAPAN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)   161

TABLE 110            JAPAN: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            162

TABLE 111            CHINA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)   163

TABLE 112            CHINA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            163

TABLE 113            INDIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)   164

TABLE 114            INDIA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            164

TABLE 115            AUSTRALIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            165

TABLE 116            AUSTRALIA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            165

TABLE 117            SOUTH KOREA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            166

TABLE 118            SOUTH KOREA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         166

TABLE 119            REST OF ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            167

TABLE 120            REST OF ASIA PACIFIC: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         167

TABLE 121            LATIN AMERICA: MACROECONOMIC OUTLOOK                 168

TABLE 122            LATIN AMERICA: MRI SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            169

TABLE 123            LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            169

TABLE 124            LATIN AMERICA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         169

TABLE 125            LATIN AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,

2023–2030 (USD MILLION)            170

TABLE 126            LATIN AMERICA: CLOSED MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            170

TABLE 127            LATIN AMERICA: MRI SYSTEMS MARKET, BY DESIGN, 2023–2030 (USD MILLION)          170

TABLE 128            LATIN AMERICA: FIXED/STATIONARY MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            171

TABLE 129            LATIN AMERICA: MRI SYSTEMS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            171

TABLE 130            LATIN AMERICA: MRI SYSTEMS MARKET, BY END USER,

2023–2030 (USD MILLION)            171

TABLE 131            BRAZIL: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)   172

TABLE 132            BRAZIL: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS, BY TYPE,

2023–2030 (USD MILLION)            173

TABLE 133            MEXICO: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            173

TABLE 134            MEXICO: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         174

TABLE 135            REST OF LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            174

TABLE 136            REST OF LATIN AMERICA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         175

TABLE 137            MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK           176

TABLE 138            MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            176

TABLE 139            MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            176

TABLE 140            MIDDLE EAST & AFRICA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         177

TABLE 141            MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,

2023–2030 (USD MILLION)            177

TABLE 142            MIDDLE EAST & AFRICA: CLOSED MRI SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            177

TABLE 143            MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY DESIGN,

2023–2030 (USD MILLION)            178

TABLE 144            MIDDLE EAST & AFRICA: FIXED/STATIONARY MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         178

TABLE 145            MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            178

TABLE 146            MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY END USER,

2023–2030 (USD MILLION)            179

TABLE 147            GCC COUNTRIES: MRI SYSTEMS MARKET, BY FIELD STRENGTH,

2023–2030 (USD MILLION)            179

TABLE 148            GCC COUNTRIES: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         180

TABLE 149            REST OF MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION)                 180

TABLE 150            REST OF MIDDLE EAST & AFRICA: HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181

TABLE 151            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MRI SYSTEMS MARKET, 2021–2025    182

TABLE 152            MRI SYSTEMS MARKET: DEGREE OF COMPETITION 185

TABLE 153            MRI SYSTEMS MARKET: FIELD STRENGTH FOOTPRINT       193

TABLE 154            MRI SYSTEMS MARKET: APPLICATION FOOTPRINT       194

TABLE 155            MRI SYSTEMS MARKET: END USER FOOTPRINT                 195

TABLE 156            MRI SYSTEMS MARKET: REGION FOOTPRINT                 196

TABLE 157            MRI SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES              199

TABLE 158            MRI SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES          200

TABLE 159            MRI SYSTEMS MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025       201

TABLE 160            MRI SYSTEMS MARKET: DEALS, JANUARY 2021–APRIL 2025           202

TABLE 161            MRI SYSTEMS MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025                203

TABLE 162            SIEMENS HEALTHINEERS: COMPANY OVERVIEW          204

TABLE 163            SIEMENS HEALTHINEERS: PRODUCTS OFFERED                 205

TABLE 164            SIEMENS HEALTHINEERS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025                 206

TABLE 165            SIEMENS HEALTHINEERS: DEALS, JANUARY 2021–APRIL 2025                207

TABLE 166            SIEMENS HEALTHINEERS: EXPANSIONS, JANUARY 2021–APRIL 2025            208

TABLE 167            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          209

TABLE 168            KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED             210

TABLE 169            KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025                 211

TABLE 170            KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–APRIL 2025                211

TABLE 171            KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2021–APRIL 2025            211

TABLE 172            GE HEALTHCARE: COMPANY OVERVIEW                 213

TABLE 173            GE HEALTHCARE: PRODUCTS OFFERED                 214

TABLE 174            GE HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–APRIL 2025            215

TABLE 175            GE HEALTHCARE: DEALS, JANUARY 2021–APRIL 2025        215

TABLE 176            GE HEALTHCARE: EXPANSIONS, JANUARY 2021–APRIL 2025           216

TABLE 177            CANON MEDICAL SYSTEMS: COMPANY OVERVIEW          218

TABLE 178            CANON MEDICAL SYSTEMS: PRODUCTS OFFERED             219

TABLE 179            CANON MEDICAL SYSTEMS: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–APRIL 2025            220

TABLE 180            CANON MEDICAL SYSTEMS: DEALS, JANUARY 2021–APRIL 2025                220

TABLE 181            FUJIFILM CORPORATION: COMPANY OVERVIEW          222

TABLE 182            FUJIFILM CORPORATION: PRODUCTS OFFERED                 223

TABLE 183            FUJIFILM CORPORATION: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–APRIL 2025            224

TABLE 184            FUJIFILM CORPORATION: DEALS, JANUARY 2021–APRIL 2025                224

TABLE 185            FONAR CORPORATION: COMPANY OVERVIEW                 226

TABLE 186            FONAR CORPORATION: PRODUCTS OFFERED                 227

TABLE 187            FONAR CORPORATION: DEALS, JANUARY 2021–APRIL 2025           227

TABLE 188            ESAOTE SPA: COMPANY OVERVIEW        228

TABLE 189            ESAOTE SPA: PRODUCTS OFFERED         228

TABLE 190            ESAOTE SPA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025 229

TABLE 191            ESAOTE SPA: DEALS, JANUARY 2021–APRIL 2025                 229

TABLE 192            SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW              230

TABLE 193            SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCTS OFFERED               231

TABLE 194            SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025                231

TABLE 195            SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: DEALS,

JANUARY 2021–APRIL 2025            232

TABLE 196            SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: EXPANSIONS, JANUARY 2021–APRIL 2025          232

TABLE 197            ASPECT IMAGING LTD.: COMPANY OVERVIEW                 233

TABLE 198            ASPECT IMAGING LTD.: PRODUCTS OFFERED                 233

TABLE 199            TIME MEDICAL HOLDING: COMPANY OVERVIEW          234

TABLE 200            TIME MEDICAL HOLDING: PRODUCTS OFFERED             234

TABLE 201            TIME MEDICAL HOLDING: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–APRIL 2025            235

TABLE 202            TIME MEDICAL HOLDING: DEALS, JANUARY 2021–APRIL 2025                235

TABLE 203            TIME MEDICAL HOLDING: EXPANSIONS, JANUARY 2021–APRIL 2025            235

TABLE 204            NEUSOFT MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW   236

TABLE 205            NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED    236

TABLE 206            NEUSOFT MEDICAL SYSTEMS CO., LTD.: DEALS, JANUARY 2021–APRIL 2025            237

TABLE 207            STERNMED GMBH: COMPANY OVERVIEW                 238

TABLE 208            STERNMED GMBH: PRODUCTS OFFERED                 238

TABLE 209            STERNMED GMBH: DEALS, JANUARY 2021–APRIL 2025           238

TABLE 210            HYPERFINE, INC.: COMPANY OVERVIEW                 239

TABLE 211            HYPERFINE, INC.: PRODUCTS OFFERED                 240

TABLE 212            HYPERFINE, INC.: DEALS, JANUARY 2021–APRIL 2025        240

TABLE 213            SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.: COMPANY OVERVIEW       241

TABLE 214            SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.: PRODUCTS OFFERED        241

TABLE 215            SHENZHEN ANKE HIGH-TECH., LTD: COMPANY OVERVIEW          242

TABLE 216            SHENZHEN ANKE HIGH-TECH., LTD: PRODUCTS OFFERED    242

TABLE 217            MAGNETICA LTD: COMPANY OVERVIEW                 243

TABLE 218            AURORA HEALTHCARE US CORP: COMPANY OVERVIEW          244

TABLE 219            INNERVISION MRI LTD.: COMPANY OVERVIEW                 245

TABLE 220            BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW              246

TABLE 221            MEDONICA CO., LTD: COMPANY OVERVIEW                 247

TABLE 222            NEOSCAN SOLUTIONS GMBH: COMPANY OVERVIEW          247

TABLE 223            KANGDA INTERCONTINENTAL MEDICAL EQUIPMENT CO., LTD.:

COMPANY OVERVIEW   248

TABLE 224            MINFOUND MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW   249

TABLE 225            SYNAPTIVE MEDICAL: COMPANY OVERVIEW                 250

TABLE 226            XINGAOYI MEDICAL EQUIPMENT CO,. LTD: COMPANY OVERVIEW   250

LIST OF FIGURES

FIGURE 1              RESEARCH DESIGN         29

FIGURE 2              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS            32

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION     33

FIGURE 4              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           34

FIGURE 5              APPROACH 1 (COMPANY REVENUE ESTIMATION)   35

FIGURE 6              REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SIEMENS HEALTHINEERS 36

FIGURE 7              APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION     37

FIGURE 8              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 38

FIGURE 9              DATA TRIANGULATION METHODOLOGY                 39

FIGURE 10            MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2025 VS. 2030 (USD MILLION)      42

FIGURE 11            MRI SYSTEMS MARKET, BY ARCHITECTURE, 2025 VS. 2030 (USD MILLION)      43

FIGURE 12            MRI SYSTEMS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)                44

FIGURE 13            MRI SYSTEMS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)       45

FIGURE 14            MRI SYSTEMS MARKET: GEOGRAPHIC SNAPSHOT          45

FIGURE 15            RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 47

FIGURE 16            HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS SEGMENT TO DOMINATE

MARKET IN 2025                48

FIGURE 17            BRAIN & NEUROLOGICAL MRI SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD                 49

FIGURE 18            HOSPITALS SEGMENT TO ACCOUNT FOR LARGEST SHARE IN 2025                50

FIGURE 19            CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD       51

FIGURE 20            MRI SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          52

FIGURE 21            PORTER’S FIVE FORCES ANALYSIS           59

FIGURE 22            ECOSYSTEM ANALYSIS  73

FIGURE 23            VALUE CHAIN ANALYSIS               75

FIGURE 24            SUPPLY CHAIN ANALYSIS             76

FIGURE 25            AVERAGE SELLING PRICE TREND OF MRI SYSTEMS, BY KEY PLAYER,

2022–2024 (USD MILLION)            79

FIGURE 26            AVERAGE SELLING PRICE TREND OF MRI SYSTEMS, BY REGION,

2022–2024 (USD MILLION)            81

FIGURE 27            PATENTS GRANTED, 2014–2024  83

FIGURE 28            IMPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY,

2020–2024 (USD THOUSAND)      85

FIGURE 29            EXPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY,

2020–2024 (USD THOUSAND)      86

FIGURE 30            NEW REVENUE POCKETS FOR PLAYERS IN MRI SYSTEMS MARKET           89

FIGURE 31            INVESTMENT & FUNDING SCENARIO, 2019–2023 (USD MILLION) 90

FIGURE 32            NUMBER OF DEALS, BY KEY PLAYER, 2019–2023                 90

FIGURE 33            TOTAL VALUE OF DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)       91

FIGURE 34            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY FIELD STRENGTH 93

FIGURE 35            KEY BUYING CRITERIA, BY END USER    94

FIGURE 36            AI-INTEGRATED MRI SYSTEMS: USE CASES                 97

FIGURE 37            PRICE IMPACT ANALYSIS             100

FIGURE 38            NORTH AMERICA: MRI SYSTEMS MARKET SNAPSHOT          139

FIGURE 39            ASIA PACIFIC: MRI SYSTEMS MARKET SNAPSHOT          157

FIGURE 40            REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2020–2024 (USD MILLION)            184

FIGURE 41            MARKET SHARE OF KEY PLAYERS, 2024  185

FIGURE 42            RANKING OF KEY PLAYERS, 2024               187

FIGURE 43            EV/EBITDA OF TOP THREE PLAYERS, 2025                 187

FIGURE 44            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF TOP THREE VENDORS, 2025                 188

FIGURE 45            BRAND/PRODUCT COMPARISON             189

FIGURE 46            MRI SYSTEMS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         191

FIGURE 47            COMPANY FOOTPRINT 192

FIGURE 48            MRI SYSTEMS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 198

FIGURE 49            SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2024)             205

FIGURE 50            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)             210

FIGURE 51            GE HEALTHCARE: COMPANY SNAPSHOT (2024)                 214

FIGURE 52            CANON MEDICAL SYSTEMS: COMPANY SNAPSHOT (2024)             219

FIGURE 53            FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024)             223

FIGURE 54            FONAR CORPORATION: COMPANY SNAPSHOT (2024)    226

FIGURE 55            SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2024)                 230

FIGURE 56            HYPERFINE, INC.: COMPANY SNAPSHOT (2024)                 239

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧